En Es
Categories

Industry News

Agfa Launches RUBEE for AI at RSNA 2020

By Medimaging International staff writers
09 Dec 2020

IllustrationAgfa HealthCare (Mortsel, Belgium) has launched RUBEE for AI at RSNA 2020 that enables hospitals to embed best in class artificial intelligence (AI) to their Enterprise Imaging ecosystem.

Hospitals, imaging departments and radiologists are under tremendous pressure, with the ever-increasing demand for images to meet today’s health challenges. RUBEE for AI lays the foundation and framework for analytically intelligent “clinical packages” embedded within Enterprise Imaging, helping improve radiology efficiency with enhanced decision support. RUBEE forms the core of the Enterprise Imaging platform. RUBEE helps visualize the metadata generated by the AI algorithms, and then uses that information to automate and optimize the clinical workflows, supporting radiologists to increase productivity and enhance informed decision making, while also maximizing the value of their own expertise.

The market for healthcare-based AI algorithms has boomed, leaving hospitals faced with an increasing number of individual applications to choose from. RUBEE for AI takes away the time-consuming guesswork of choosing and implementing each algorithm, with specialty AI packages that address specific clinical needs. The AI applications have been carefully selected to verify they come from reliable solution providers, use the right datasets, follow industry standards, and are integrated seamlessly. Hospitals may also decide to use RUBEE for AI to embed their own choice of AI applications, including for research and academic use leveraging the Enterprise Imaging academic teaching and peer learning workflows.

With the RUBEE for AI, specialty packages are seamlessly embedded into radiology workflows. The Breast AI package provides powerful tools for cancer risk-based triage, along with natively embedded CAD AI visualizations and advanced 2D/3D mammography tools, while the CT Lung AI package improves visualization of nodules and comparisons, enables sorting and triage, and smart display of AI findings.

“With Enterprise Imaging, Agfa HealthCare has already taken a forward thinking approach, with a single, multi-specialty industry recognized imaging platform,” said Dr. Anjum Ahmed, Chief Medical Officer, and Global Director of Innovation at Agfa HealthCare. “RUBEE for AI leverages this platform, and enables a care pathway focused curation of niche and specialty focused AI applications. This approach is much more clinically valuable, analytically intelligent and productivity driven compared to a separate AI platform or marketplace. And by providing radiologists with carefully curated AI decision support tools, embedded in their Enterprise Imaging solution, we support them to maximize the value of their own skills and expertise, and become consultative powerhouse of evidence-based intelligence.”





E-mail Print
FaceBook Twitter Google+ Linked in

Agfa Healthcare

Provides integrated IT solutions, state-of-the-art diagnostic imaging and contrast media solutions for hospitals and healthcare centers
Silver member
More info

More articles about Agfa Healthcare

09 Dec 2020
Agfa Launches SmartXR DR Portfolio That Offers X-Ray Intelligence at Work at RSNA 2020
Agfa HealthCare (Mortsel, Belgium) has launched its SmartXR digital radiography (DR) portfolio at RSNA 2020 that uses a unique combination of hardware and AI-powered software to lighten radiographers’ workloads and provide image acquisition support.
Read More
30 Dec 2019
AGFA to Sell Part of HealthCare IT Business to Dedalus Holding
 The Agfa-Gevaert Group (Mortsel, Belgium) has entered into exclusive negotiations to sell a part of its HealthCare IT business to Dedalus Holding S.p.A. (Florence, Italy). The HealthCare IT business consists of Healthcare Information Solutions and Integrated Care activities, as well as Imaging IT activities, all of which are tightly integrated into Healthcare Information Solutions activities, mainly in the DACH region, France and Brazil.
Read More
15 Oct 2019
Agfa Showcases AI and DR Portfolio at JFR 2019
Agfa Radiology Solutions showcased its artificial intelligence (AI) and digital radiography (DR) product portfolio at France’s national radiology congress, the Journées Francophones de Radiologie (JFR), held in Paris on October 11-14.
Read More
27 Sep 2019
Agfa Demonstrates AI-Powered Intelligent DR Solutions at RSNA 2019
Agfa NV will present its intelligent radiography powered by the MUSICA Acquisition Workstation, the digital Nerve Center of every Agfa DR system, including the launch of a new, groundbreaking direct radiography (DR) unit at RSNA 2019, to be held December 1-6, in Chicago, IL, USA.
Read More
28 Aug 2017
Agfa Plans to Separate Healthcare IT Business
Agfa-Gevaert NV’s board of directors has asked the management to study how the HealthCare IT activities can be organized into a stand-alone legal entity structure and organization within the Agfa-Gevaert Group.
Read More
13 Dec 2016
CompuGroup Medical Ends Talks with Agfa on Potential Deal
CompuGroup Medical SE, a provider of medical software and other products including X-ray machines, has ended discussions over its potential acquisition of Agfa-Gevaert, which offers analogue and digital imaging systems and IT solutions for the healthcare sector.
Read More
13 Dec 2016
Agfa HealthCare to Implement Enterprise Imaging for Radiology in Amsterdam
Agfa HealthCare has signed an agreement to implement Enterprise Imaging for Radiology in the new Acibadem International Medical Center, which is soon expected to open in Amsterdam for providing a range of services to Dutch as well as international patients.
Read More

Additional news

27 Jun 2022
Robot-Assisted Surgical Devices Market Driven by Increased Demand for Patient-Specific Surgeries
Given the growing incidence of lifestyle diseases and demand for affordable healthcare, effective surgery using robotic devices can result in a decline in treatment costs and drive the growth of the global robot-assisted surgical devices (RASD) market.
Read More
24 Jun 2022
Fujirebio Acquires ADx NeuroSciences to Speed Development of Neurodegenerative Diseases Diagnostic Tests
Fujirebio Holdings, Inc. (Tokyo, Japan) has announced the acquisition of ADx NeuroSciences (Gent, Belgium) for EUR 40 million in a deal that is expected to close in July 2022, pending the satisfaction of customary closing conditions.
Read More
23 Jun 2022
Hospital Microbiology Testing Market Driven by Increasing Prevalence of Chronic Diseases
Rising medical expenditure as well as the presence of well-established modern healthcare infrastructure in various developed as well as developing regions is fueling the growth of the global hospital microbiology testing market.
Read More
22 Jun 2022
Global Minimally Invasive Surgery (MIS) Market to Surpass USD 325 Billion by 2031
The global MIS market is projected to surpass USD 325 billion by 2031, driven by growing patient awareness of the advantages of MIS over open surgeries, continuous innovation in surgical robots, and constant advancements in other MIS-associated technologies during the 2022-2031 forecast period.
Read More
21 Jun 2022
Medix Biochemica Acquires IVD Raw Materials Producer Bioresource Technology
Medix Biochemica (Espoo, Finland) has acquired 100% of the shares of Bioresource Technology (BRT, Weston, FL, USA) to broaden its base matrix capabilities and further strengthen its local presence in the US market.
Read More
21 Jun 2022
Global Bedside Testing Market to Witness Promising Prospects in Critical Care
Point-of-care or point-of-use diagnostics, also known as bedside testing, has gained increased prominence in analytical testing over the past few years as it provides clinically relevant information without the need for a dedicated laboratory.
Read More
20 Jun 2022
Global Sepsis Diagnostics Market Driven by Rising Hospital-Acquired Illnesses
The global sepsis diagnostics market is expected to grow at a CAGR of 8.3% during the period 2022-2028 to reach almost USD 0.88 billion by 2028, driven by a rise in the number of hospital-acquired illnesses and the rapidly growing molecular diagnostics market, although the high cost of automated diagnostic instruments could hamper market growth.
Read More
14 Jun 2022
BD Partners with Mayo Clinic Platform for Access to World's Largest Collection of Clinical Data
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA) has entered into a collaboration with Mayo Clinic Platform (Rochester, MN, USA) to access de-identified patient data from Mayo Clinic Platform_Discover.
Read More
14 Jun 2022
Quidel Partners with Global Lyme Alliance, Leads in Lyme Disease Testing
Quidel Corporation (San Diego, CA, USA) is joining forces with Global Lyme Alliance (Stamford, CT, USA) to heighten public awareness around Lyme disease during Lyme Disease Awareness Month (in May) and beyond.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions